Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge

Expert Rev Clin Immunol. 2010 Nov;6(6):821-6. doi: 10.1586/eci.10.77.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antigens, Neoplasm / immunology
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Contraindications
  • Female
  • Fetal Development / drug effects
  • Humans
  • Placental Circulation
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy*
  • Pregnancy Complications, Neoplastic / immunology
  • Rituximab
  • Toxicity Tests / trends
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, Neoplasm
  • Rituximab
  • Trastuzumab